Challenges associated with developing treatments for solid and rare tumors
What we are learning about CLL treatments and the microenvironment
How are viral and bacterial infections managed in myeloma patients?
History of gene therapies
Inotuzumab and blinatumomab: the most exciting ALL news from EHA 2017